Dr Thurn for Stockhead on activities to lift the FDA clinical hold on NUZ-001
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Neurizon a question about this update.